Might promote heart health Heart disease is linked to high levels of an amino acid called homocysteine
Exenatide extended-release carries a boxed warning for thyroid C-cell tumors and is contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
This is why GLP-1 microbiome support through food choices matters
I did some math and realized that if I stopped going to the drive-thru and skipped happy hour beers that lead to pub food dinners and didnt pick up multiple six-packs of beer a week, I could eliminate about $500 a month from my dining-out budget
We believe the ability to blunt the weight regain that we typically see when patients stop GLP-1 agonist therapy like semaglutide is clinically significant, and reinforces the target product profile for nimacimab, which can potentially serve multiple needs in the obesity treatment paradigm, not just as a non-incretin add-on or combination, but also potentially in the maintenance setting. Punit Dhillon, President and CEO, added, While nimacimab 200 mg alone did not result in significant weight loss, we are encouraged that this same dose in combination with semaglutide demonstrated 26-week weight loss comparable to tirzepatide and other incretin combinations, without any added safety concerns
Simultaneously CD8 + T cell infiltration is significantly elevated in AD brain tissues